S100A8 and colorectal carcinoma: Recent examples in the literature show that similar approaches can successfully yield novel serum biomarkers for CRC, such as nicotinamide-N-methyltransferase [11], proteasome activator complex subunit [12], S100A8, and S100A9 [13,14].